Background and Aim: Hypoxemia is associated with neurological deterioration in stroke patients. Severity of stroke may affect the benefit of oxygen supplementation. Abnormal breathing patterns among stroke patients increase the risk of hypoxemia. High flow nasal cannula (HFNC) has benefits of positive airway pressure throughout the breathing cycle. We aimed to assess the effect of HFNC on oxygen desaturation index (ODI) and neurological outcomes in stroke patients with moderate and severe severities. Methods: We conducted a single-center, prospective, RCT. The patients with acute ischemic stroke admitted in a stroke unit within 72 hours after the onset were enrolled. Inclusion criteria were stroke patients with moderate and severe severities and low risk of prior OSA. The eligible patients were randomly assigned to high flow, low flow and no oxygen groups. The primary outcome was ODI in the first day of treatment , while secondary outcomes were 1) numbers of patients with oxygen desaturation, and 2) NIHSS change at seventh day of admission.
INTRODUCTION: Aerococci are gram positive cocci typically associated with genitourinary infections. Aerococcus viridans is a pathogen typically seen in urinary tract infections, rarely causing systemic infections including bacteremia and endocarditis. We present a case of A. viridans bacteremia with infective endocarditis and associated septic emboli, without evidence of concomitant urinary tract infection. CASE PRESENTATION:An 84-year-old woman presented to the hospital with altered mental status and left sided visual field changes. Vitals were consistent with sepsis and she was empirically started on Ceftriaxone. Magnetic resonance imaging demonstrated extensive multifocal infarcts in the right occipital lobe and thalamus. Trans-esophageal echocardiogram revealed a two millimeter focal echodensity on the left coronary cusp of the aortic valve, consistent with infective endocarditis. Blood cultures were positive for pan-susceptible Acinetobacter with Aerococcus viridans resistant to beta lactams. A urine sample collected on admission grew only Escherichia coli. The patient was started on a six-week course of intravenous Vancomycin. Repeat blood cultures collected after completion of antibiotic therapy showed resolution of bacteremia. A follow up trans-thoracic echocardiogram did not show any persistent endocarditis.DISCUSSION: Aerococcus species are typically found in the urine, but this patient's urine culture was negative for aeroccus viridans. Of the two bacteria seen on blood culture, Aerococcus is thought to be the more likely pathogen of the endocarditis leading to septic emboli. Endocarditis is more frequently due to Gram positive organisms, and it is less likely that Acinetobacter, a Gram negative rod, would be the underlying pathogen. To further support our explanation, there are morphologic similarities between A. viridans and viridans streptococci, which are known to cause endocarditis. In terms of treatment, Aerococcus species are frequently susceptible to penicillins. In this case, A. viridans was resistant to both penicillins and cephalosporins, requiring therapy with Vancomycin.CONCLUSIONS: In the past, exact identification of organisms like Aerococcus were difficult and the clinical significance of many isolates remained obscure. Aerococcus urinae is the most documented strain with reports of urinary tract infection leading to endocarditis. We report a rare cause of idiopathic A. viridans resistant to penicillin causing infective endocarditis and cerebral emboli without associated genitourinary pathology. Aerococcus endocarditis, though rarely documented, can have severe complications including septic emboli with a significant risk of morbidity and mortality. Regardless of the source, Aerococcus infections with progression to bacteremia should raise suspicion for endocarditis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.